MSC Therapy for Graft-versus-Host Disease: What 15 RCTs and a Biomarker-Guided Trial Tell Us

A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.

Lire la suite...

Pediatric Applications of Stem Cell Therapy

Stem cell therapy holds immense promise for treating rare diseases in children, offering hope for conditions that are often difficult to manage with conventional treatments. Mesenchymal stem cells (MSCs) are particularly valuable in pediatric applications due to their safety and regenerative potential, addressing disorders like cerebral palsy, muscular dystrophy, and...

Lire la suite...

Revolutionizing Cancer Treatment with CIK Cells

When it comes to modern medicine, advancements in cancer treatment and immune system rejuvenation are among the most exciting fields of study. One such breakthrough involves Cytokine-Induced Killer (CIK) cells. These specialized immune cells are showing promise in the fight against cancer and even offer potential for rejuvenating the immune...

Lire la suite...

Hematopoietic Stem Cell Transplantation: An Advanced Treatment Option for Blood-Related Diseases

Hematopoietic stem cell transplantation (HSCT) is a medical procedure that involves the transplantation of stem cells that are capable of forming blood cells. This advanced treatment option is used to treat various blood-related diseases such as leukemia, lymphoma, and multiple myeloma. HSCT has been found to be highly effective in...

Lire la suite...

Cellules dormantes : la phase de repos des cellules souches récemment découverte pourrait endormir les tumeurs cérébrales

Les chercheurs en génie biomédical ont développé un nouvel outil de classification cellulaire qui examine à plus haute résolution le cycle de vie des cellules souches neuroépithéliales, ce qui a conduit à la découverte et à l'exploration d'une nouvelle phase de repos appelée Neural G0. Ces connaissances pourraient aider les scientifiques à mieux comprendre les tumeurs cérébrales du gliome et à développer...

Lire la suite...

Identification des marqueurs de la souche des cellules souches du cancer du foie à l'aide d'une analyse comparative d'ensembles de données publiques

Les National Institutes of Health et d'autres agences financent des expériences de génomique et de transcriptomique ('omique) à haut débit qui déposent des échantillons numériques de données dans le domaine public à une échelle de plus en plus importante.1,2 The importance of these digital samples of data is further illustrated by the growing number of linked peer-reviewed publications...

Lire la suite...
Top